
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Medulloblastoma other diagnostic studies
Introduction
Overview
Overview
Bromodeoxyuridine labeling study may be helpful in the diagnosis of medulloblastoma. An elevated bromodeoxyuridine labeling index is suggestive of a rapid growth rate of medulloblastoma.[1]
Bromodeoxyuridine Labeling Study
Bromodeoxyuridine Labeling Study
- Bromodeoxyuridine labeling study may be helpful in the diagnosis of medullblastoma. An elevated bromodeoxyuridine labeling index is suggestive of a rapid growth rate of medulloblastoma.[1]
- The bromodeoxyuridine labeling index of medulloblastoma is measured between:
- 6.8 to 26.9% on dilute hydrochloric acid hydrolysis in vitro technique
- 7.5 to 28.8% on microwave heating in vitro technique
References
References
- ↑ 1.0 1.1 Onda K, Davis RL, Edwards MS (1996). “Comparison of bromodeoxyuridine uptake and MIB 1 immunoreactivity in medulloblastomas determined with single and double immunohistochemical staining methods”. J Neurooncol. 29 (2): 129–36. PMID 8858517.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
